Use of Total Lymphocyte Count for Monitoring Response to Antiretroviral Therapy

Clinical Infectious Diseases

Volumn 38, Issue 2, 2004, Pages 257-262

  Schreibman, Tanya ^a   Friedland, Gerald ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; TUBERCULOSTATIC AGENT;

CELL ASSAY; CORRELATION ANALYSIS; COST BENEFIT ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG MONITORING; GEOGRAPHIC DISTRIBUTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; LABORATORY TEST; LYMPHOCYTE COUNT; MALARIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SUPERINFECTION; TUBERCULOSIS; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHEMOPREVENTION; DISEASE PROGRESSION; DRUG MONITORING; FORECASTING; HIV INFECTIONS; HUMANS; LYMPHOCYTE COUNT;

EID: 1642456563     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/380792     Document Type: Review

References (28)

1. Hosseinipour MC, Kazembe PN, Sanne IM, et al. Challenges in delivering antiretroviral treatment in resource poor countries. AIDS 2002; 16:S177-87.
2. Kumarasamy N, Mahajan AP, Flanigan TP, et al. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr 2002; 31:378-83.
3. Nkengasong JN. Laboratory monitoring of antiretroviral therapy in developing countries (abstract 527]. In: Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Seattle: Foundation for Retrovirology and Human Health, 2002.
4. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach: executive summary. April 2002. IAPAC Monthly 2002; 8:168-75.
5. + percentage in HIV-infected persons. JAMA 1993; 269:622-6.
6. Post FA, Wood R, Maartens G. CD4 and total lymphocyte counts as predictors of HIV disease progression. QJM 1996; 89:505-8.
7. Jacobson MA, Liu L, Khayam-Bashi H, et al. Absolute or total lymphocyte count as a marker for initiating highly active antiretroviral therapy [abstract MoPeB3100]. In: Programs and abstracts of the 14th International AIDS Conference (Barcelona). Barcelona: International AIDS Society, 2002.
8. Kohreanudom S. The benefit of using total lymphocyte count for monitoring the treatment of HIV/AIDS patients in Thailand [abstract MoPeB3103]. In: Programs and abstracts of the 14th International AIDS Conference (Barcelona). Barcelona: International AIDS Society, 2002.
9. Tassie JM, Marquardt T, Abele M, et al. Usefulness of indirect markers for identifying patients severely immunocompromised in rural Malawi [abstract MoPeB3101]. In: Programs and abstracts of the 14th International AIDS Conference (Barcelona). Barcelona: International AIDS Society, 2002.
10. Mofenson LM, Harris DR, Moye J, et al. Low technology predictors of mortality for resource-poor settings: association of total lymphocyte count (TLC) and white blood cell count (WBC) with mortality in HIV-1 infected children [abstract B10171]. In: Programs and abstracts of the 14th International AIDS Conference (Barcelona). Barcelona: International AIDS Society, 2002.
11. Mekonnen Y, Dukers N, Sanders E, et al. Simple predictive markers of death in HIV-1 infected Ethiopians and their relevance in the decision of initiation of antiretroviral therapy (ART) [abstract TuPeB4669]. In: Programs and abstracts of the 14th International AIDS Conference (Barcelona). Barcelona: International AIDS Society, 2002.
12. Gange SJ, Lau B, Phair J, et al. Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy. AIDS 2003; 17:119-21.
13. Okiror J, Otim T, Segonga P. Comparison of CD4 levels with absolute lymphocyte counts in clients with HIV at JCRC-Uganda [abstract B10175). In: Programs and abstracts of the 14th International AIDS Conference (Barcelona). Barcelona: International AIDS Society, 2002.
14. Mbanya DNS, Assah FK. Correlation between total lymphocyte counts and CD4 counts in HIV-1 positive adults in Yaounde [abstract MoPeB3099]. In: Programs and abstracts of the 14th International AIDS Conference (Barcelona). Barcelona: International AIDS Society, 2002.
15. + percentage in a group of HIV-1-infected South African patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:238-44.
16. Kassa E, Rinke de Wit TF, Hailu E, et al. Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers. AIDS 1999; 13:381-9.
17. Flanigan TP, Mahajan A, Kumarasamy N, et al. Total lymphocyte count (TLC) as a surrogate for CD4 count to initiate and monitor HAART in resource-limited countries [abstract 456-W]. In: Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Seattle: Foundation for Retrovirology and Human Health, 2002.
18. Spacek LA, Griswold M, Quinn TC, et al. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings. AIDS 2003; 17:1311-7.
19. Badri M, Wood R. Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings. AIDS 2003; 17:541-5.
20. + lymphocyte count in African patients co-infected with HIV and tuberculosis [comment]. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:386-91.
21. Chen RY, Westfall AO, Hardin M, et al. Complete blood count as a surrogate CD4 marker for HIV monitoring in resource-limited settings [abstract 168]. In: Program and abstracts of the 10th Conference on Retroviruses and Opportunistic Infections (Boston). Boston: Foundation for Retrovirology and Human Health, 2003.
22. Morris L, Martin D, Bredell H, et al. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis in South African patients. J Infect Dis 2003; 187:1967-71.
23. Hoffman IF, Jere CS, Taylor TE, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentrations. AIDS 1999; 13:487-94.
24. Verhoeff FH, Brabin BJ, Har CA, et al. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health 1999; 4:5-12.
25. Rodriguez W, Mohanty M, Christodoulides N, et al. Development of affordable, portable CD4 counts for resource-poor settings using microchips [abstract 1751b]. In: Program and abstracts of the 10th Conference on Retroviruses and Opportunistic Infections (Boston). Boston: Foundation for Retrovirology and Human Health, 2003.
26. + T-cell counts on "single-platform" flow cytometers I. Primary CD4 gating. Br J Haematol 2000; 111:1198-208.
27. +-T-cell counting by flow cytometry: CD45 gating for volumetric analysis. Clin Diagn Lab Immunol 2002; 9:1085-94.
28. + T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settings. J Immunol Methods 2001; 257:145-54.